Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Guarding the Gate: Remote Structured Assessments to Enhance Enrollment Precision in Depression Trials.

Freeman MP, Pooley J, Flynn MJ, Baer L, Mischoulon D, Mou D, Fava M.

J Clin Psychopharmacol. 2017 Apr;37(2):176-181. doi: 10.1097/JCP.0000000000000669.

PMID:
28187008
2.

Comparisons of Subthreshold Versus Full Posttraumatic Stress Disorder Distinguished by Subjective Functional Impairment Among Train Drivers: A Population-Based Nationwide Study in South Korea.

Baek JH, Kim JH, Kim BN, Park SJ, Fava M, Mischoulon D, Lee D, Jeon HJ.

Psychiatry Investig. 2017 Jan;14(1):1-7. doi: 10.4306/pi.2017.14.1.1.

3.

Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison.

Heo JY, Kim K, Fava M, Mischoulon D, Papakostas GI, Kim MJ, Kim DJ, Chang KJ, Oh Y, Yu BH, Jeon HJ.

J Psychiatr Res. 2016 Dec 12;87:61-70. doi: 10.1016/j.jpsychires.2016.12.010. [Epub ahead of print]

PMID:
28017916
4.

Gender Differences in Somatic Symptoms and Current Suicidal Risk in Outpatients with Major Depressive Disorder.

Jeon HJ, Woo JM, Kim HJ, Fava M, Mischoulon D, Cho SJ, Chang SM, Park DH, Kim JW, Yoo I, Heo JY, Hong JP.

Psychiatry Investig. 2016 Nov;13(6):609-615.

5.

Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.

Mischoulon D, Shelton RC, Baer L, Bobo WV, Curren L, Fava M, Papakostas GI.

J Clin Psychiatry. 2016 Nov 8. doi: 10.4088/JCP.15m10426. [Epub ahead of print]

PMID:
27835715
6.

Mindfulness-based cognitive therapy for depressed individuals improves suppression of irrelevant mental-sets.

Greenberg J, Shapero BG, Mischoulon D, Lazar SW.

Eur Arch Psychiatry Clin Neurosci. 2016 Nov 9. [Epub ahead of print]

PMID:
27830339
7.

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.

Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Soskin DP, Fava M.

J Affect Disord. 2017 Jan 15;208:6-14. doi: 10.1016/j.jad.2016.08.029.

PMID:
27736689
8.

Cross-national differences in hypochondriasis symptoms between Korean and American outpatients with major depressive disorder.

Chang KJ, Kim K, Fava M, Mischoulon D, Hong JP, Kim DJ, Heo JY, Choi H, Jeon HJ.

Psychiatry Res. 2016 Nov 30;245:127-132. doi: 10.1016/j.psychres.2016.08.019.

PMID:
27541348
9.

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP.

Mol Psychiatry. 2016 Oct;21(10):1483-4. doi: 10.1038/mp.2016.140. No abstract available.

10.

Does folic acid interfere with lamotrigine?

Mischoulon D, Zajecka J, Freeman MP, Fava M.

Lancet Psychiatry. 2016 Aug;3(8):704-5. doi: 10.1016/S2215-0366(16)30167-5. No abstract available.

PMID:
27475760
11.

Effects of Mindfulness-Based Cognitive Therapy on Body Awareness in Patients with Chronic Pain and Comorbid Depression.

de Jong M, Lazar SW, Hug K, Mehling WE, Hölzel BK, Sack AT, Peeters F, Ashih H, Mischoulon D, Gard T.

Front Psychol. 2016 Jun 30;7:967. doi: 10.3389/fpsyg.2016.00967.

12.

Lifetime suicidal ideation and attempt in adults with full major depressive disorder versus sustained depressed mood.

Yoo HJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Heo JY, Kim K, Jeon HJ.

J Affect Disord. 2016 Oct;203:275-80. doi: 10.1016/j.jad.2016.06.007.

PMID:
27314814
13.

Inflammatory cytokines in major depressive disorder: A case-control study.

Cassano P, Bui E, Rogers AH, Walton ZE, Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah A, Worthington J, Hoge EA, Alpert J, Fava M, Wong KK, Simon NM.

Aust N Z J Psychiatry. 2017 Jan;51(1):23-31. doi: 10.1177/0004867416652736.

PMID:
27313138
14.

Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder.

Myung W, Han CE, Fava M, Mischoulon D, Papakostas GI, Heo JY, Kim KW, Kim ST, Kim DJ, Kim DK, Seo SW, Seong JK, Jeon HJ.

Transl Psychiatry. 2016 Jun 7;6(6):e835. doi: 10.1038/tp.2016.110.

15.

Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder.

Baek JH, Kim HJ, Fava M, Mischoulon D, Papakostas GI, Nierenberg A, Heo JY, Jeon HJ.

Psychiatry Investig. 2016 May;13(3):321-6. doi: 10.4306/pi.2016.13.3.321.

16.

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.

Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, Nyer M, Cassano P, Mischoulon D, Alpert JE, Brown EN, Nock MK, Fava M, Cusin C.

J Clin Psychiatry. 2016 Jun;77(6):e719-25. doi: 10.4088/JCP.15m10056.

PMID:
27232360
17.

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses.

Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH.

Am J Psychiatry. 2016 Jun 1;173(6):575-87. doi: 10.1176/appi.ajp.2016.15091228.

PMID:
27113121
18.

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.

Cusin C, Ionescu DF, Pavone KJ, Akeju O, Cassano P, Taylor N, Eikermann M, Durham K, Swee MB, Chang T, Dording C, Soskin D, Kelley J, Mischoulon D, Brown EN, Fava M.

Aust N Z J Psychiatry. 2017 Jan;51(1):55-64. doi: 10.1177/0004867416631828.

PMID:
26893373
19.

Loss of sexual interest and premenstrual mood change in women with postpartum versus non-postpartum depression: A nationwide community sample of Korean adults.

Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Lee DW, Heo JY, Jeon HJ.

J Affect Disord. 2016 Feb;191:222-9. doi: 10.1016/j.jad.2015.11.050.

PMID:
26682491
20.

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.

Fava M, Johe K, Ereshefsky L, Gertsik LG, English BA, Bilello JA, Thurmond LM, Johnstone J, Dickerson BC, Makris N, Hoeppner BB, Flynn M, Mischoulon D, Kinrys G, Freeman MP.

Mol Psychiatry. 2016 Oct;21(10):1372-80. doi: 10.1038/mp.2015.178.

Items per page

Supplemental Content

Loading ...
Support Center